Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mattina

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
The Journal of Antimicrobial Chemotherapy|May 1, 1984
In-vitro antibacterial activity of Sch 25393, a fluorinated analogue of thiamphenicolG Marca, R Mattina, F Dubini, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|June 1, 1987
In vitro evaluation of CM 40876, a new third-generation cephalosporinA Raimondi, C Cocuzza, G Musmanno, et al.
Journal of Chemotherapy (Florence, Italy)|November 30, 2004
In vitro activity of thiamphenicol, erythromycin and fluoroquinolones against Legionella pneumophilaG Bonfiglio, A Lanzafame, L Santini, et al.
Journal of Chemotherapy (Florence, Italy)|July 1, 1989
In vitro antibacterial activity of lenampicllinR Mattina, M G Bellotti, C E Cocuzza
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|June 1, 1987
Pharmacokinetic studies in rats with ofloxacin and MF-934, a new fluorinated quinoloneR Mattina, M Bellotti, A Raimondi, et al.
Giornale Di Batteriologia, Virologia Ed Immunologia|July 1, 1984
[Bactericidal activity of octophene]M G Bellotti, A Raimondi, R Mattina, et al.
Giornale Italiano Di Chemioterapia|January 1, 1977
[Microbiological characteristics of kanendomycin]G Blandino, R Mattina, A Speciale, et al.
Chemotherapy|January 1, 1991
In vitro activity of a new quinolone, rufloxacin, against nosocomial isolatesR Mattina, C E Cocuzza, M Cesana, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2003
Pharmacodynamics of levofloxacin and ciprofloxacin in a murine pneumonia model: peak concentration/MIC versus area under the curve/MIC ratiosF Scaglione, J W Mouton, R Mattina, et al.
Therapeutic Drug Monitoring|February 1, 1992
Steady-state pharmacokinetics of rufloxacin in elderly patients with lower respiratory tract infectionsR Cogo, R Rimoldi, R Mattina, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
The Journal of Antimicrobial Chemotherapy|May 1, 1984
In-vitro antibacterial activity of Sch 25393, a fluorinated analogue of thiamphenicolG Marca, R Mattina, F Dubini, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|June 1, 1987
In vitro evaluation of CM 40876, a new third-generation cephalosporinA Raimondi, C Cocuzza, G Musmanno, et al.
Journal of Chemotherapy (Florence, Italy)|November 30, 2004
In vitro activity of thiamphenicol, erythromycin and fluoroquinolones against Legionella pneumophilaG Bonfiglio, A Lanzafame, L Santini, et al.
Journal of Chemotherapy (Florence, Italy)|July 1, 1989
In vitro antibacterial activity of lenampicllinR Mattina, M G Bellotti, C E Cocuzza
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|June 1, 1987
Pharmacokinetic studies in rats with ofloxacin and MF-934, a new fluorinated quinoloneR Mattina, M Bellotti, A Raimondi, et al.
Giornale Di Batteriologia, Virologia Ed Immunologia|July 1, 1984
[Bactericidal activity of octophene]M G Bellotti, A Raimondi, R Mattina, et al.
Giornale Italiano Di Chemioterapia|January 1, 1977
[Microbiological characteristics of kanendomycin]G Blandino, R Mattina, A Speciale, et al.
Chemotherapy|January 1, 1991
In vitro activity of a new quinolone, rufloxacin, against nosocomial isolatesR Mattina, C E Cocuzza, M Cesana, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2003
Pharmacodynamics of levofloxacin and ciprofloxacin in a murine pneumonia model: peak concentration/MIC versus area under the curve/MIC ratiosF Scaglione, J W Mouton, R Mattina, et al.
Therapeutic Drug Monitoring|February 1, 1992
Steady-state pharmacokinetics of rufloxacin in elderly patients with lower respiratory tract infectionsR Cogo, R Rimoldi, R Mattina, et al.
Pageof 7